- Published at
- by manilatimes.net
neutral
neutral
News for OKYO Pharma Limited (OKYO.L)
- Published at
- by gurufocus.com
neutralneutralOKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
LONDON and NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ( OKYO), a clinical-stage biopharmaceutical company developing innovative therapies- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
neutralneutral- Published at
- by investing.com
neutralneutralOKYO begins patient enrollment for Phase 2 NCP trial By Investing.com
OKYO begins patient enrollment for Phase 2 NCP trial- Published at
- by rttnews.com
mixedmixedPre-market Movers: SQNS, MNTS, UBXG, PRTG, PTWO…
France-based semiconductor business Sequans Communications S.A. (SQNS) is up over 146 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.- Published at
- by investing.com
positivepositiveOKYO Pharma secures key European patent for eye treatment By Investing.com
OKYO Pharma secures key European patent for eye treatment- Published at
- by benzinga.com
mixedmixedWhy ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Conagra Brands (NYSE:CAG)
Loading... Loading... Shares of Conagra Brands, Inc. CAG fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales res...- Published at
- by investing.com
positivepositiveOKYO Pharma maintains stock target, Buy rating amid positive trial data By Investing.com
OKYO Pharma maintains stock target, Buy rating amid positive trial data- Published at
- by benzinga.com
mixedmixedWhy Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Leidos Holdings (NYSE:LDOS)
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.- Published at
- by benzinga.com
mixedmixedWhy Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket - Salarius Pharmaceuticals (NASDAQ:SLRX)
Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results.- Published at
- by rttnews.com
mixedmixedPre-market Movers: DBGI, RA, AMBA, NSTC, BMAC…
Given below is a list of some of the stocks making big moves in Wednesday's pre-market trading (as of 07.55 A.M. ET)..- Published at
- by benzinga.com
mixedmixedWhy Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Aehr Test Systems (NASDAQ:AEHR), ACADIA Pharmaceuticals (NASDAQ:ACAD)
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.- Published at
- by marketscreener.com
positivepositiveInspirit Energy reports progress on Inspirit Charger
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- OKYO Pharma Limited - UK-based preclinical... | March 16, 2023- Published at
- by rttnews.com
mixedmixedPre-market Movers: SIVB, ZVSA, BNED, SSYS, SOBR…
The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET)..- Published at
- by rttnews.com
mixedmixedPre-market Movers: ARBE, SGML, ATNM, BTCS, OKYO…
The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.05 A.M. ET)..- Published at
- by prnewswire.com
positivepositiveOptimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik
/PRNewswire/ -- Optimum Strategic Communications ("Optimum"), the specialist life sciences communications consultancy, today announces that it has hired...- Published at
- by marketscreener.com
positivepositiveOKYO Pharma : Half Year Results
20.09.11 - CDC - Interim Financials to 30 June 2011 - clean OKYO Pharma Limited Interim results for the six months to 30 September 2022 London and... | December 31, 2022